Advertisement

Topics

Epilepsy Therapy Project Company Profile

08:21 EDT 20th September 2018 | BioPortfolio

Epilepsy is a neurological disorder that affects approximately three million Americans and 50 million people worldwide. Epilepsy has many potential causes, but often no definitive cause is found. Approximately 200,000 new cases of epilepsy will be diagnosed in the United States this year affecting as many people as breast cancer. The need for more effective therapies is acutely felt by the millions of people worldwide who live with persistent seizures or intolerable side effects of treatment.


News Articles [1537 Associated News Articles listed on BioPortfolio]

Delaying epilepsy onset could reduce impact on development

The case of a young boy with a rare genetic disorder over

LivaNova launches clinical registry to evaluate VNS therapy treatment for drug-resistant epilepsy patients

The comprehensive outcomes registry in subjects with epilepsy treated with VNS Therapy (CORE-VNS) study will enroll up to 2,000 patients with five-year follow-up data, yielding one of the The post Li...

Gene-Therapy against Epilepsy - CombiGene

Serial biotech entrepreneur Bengt Westrin talks with Nigel Borshell of PharmaVentures about his latest enterprise, a Swedish preclinical CNS company called CombiGene that has been formed further to an...

2018 Epilepsy Pipeline Highlights – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Epilepsy Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. Epilepsy Pipeline Highlights – 20...

CombiGene receives €3.3m from Horizon 2020

Horizon 2020, the EU framework programme for research and development, will invest in CombiGene s ongoing development and commercialisation of its gene therapy project focussing on difficult-to-treat ...

Most Deaths Among Kids With Epilepsy Due to Infection

A new study shows that only about 10 of 88 deaths in children with epilepsy were due to sudden unexpected death in epilepsy (SUDEP). Medscape Medical News

FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy

The FDA has granted premarket approval for Medtronic's deep-brain stimulation therapy as adjunctive treatment for seizure reduction in adults with refractory epilepsy, the company announced. FDA App...

Brain-heart activity predicts post-malaria epilepsy in mice

(Society for Neuroscience) Animals that develop epilepsy after an infection can be identified as early as three months prior to their first seizure by measuring interactions between the brain and the ...

Drugs and Medications [91 Associated Drugs and Medications listed on BioPortfolio]

Keppra [UCB, Inc.]

These highlights do not include all the information needed to use KEPPRA safely and effectively. See full prescribing information for KEPPRA. KEPPRA (levetiracetam) tablets, for oral use KEPPRA (levet...

Niacor(niacin tablets, usp)500 mg [UPSHER-SMITH LABORATORIES, INC.]

NIACOR(Niacin Tablets, USP)500 mg

Topiramate [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use topiramate safely and effectively. See full prescribing information for topiramate tablets.Topiramate Tablets for Oral UseInitial U.S....

Topiramate [Greenstone LLC]

These highlights do not include all the information needed to use topiramate safely and effectively. See full prescribing information for topiramate tablets.topiramate tablets for oral useInitial U.S....

Lipofen [Kowa Pharmaceuticals America Inc.]

These highlights do not include all the information needed to use LIPOFEN® safely and effectively. See full prescribing information for LIPOFEN®. LIPOFEN® (fenofibrate capsules, USP)Initial U.S. Ap...

PubMed Articles [3416 Associated PubMed Articles listed on BioPortfolio]

Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop.

Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.

Juvenile myoclonic epilepsy (JME) is an epileptic syndrome often regarded as one in which seizures are relatively easy to control. Individuals with JME, however, often require lifelong therapy to rema...

Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review.

Metabolic epilepsy is a metabolic abnormality which is associated with an increased risk of epilepsy development in affected individuals. Commonly used antiepileptic drugs are typically ineffective ag...

Levetiracetam efficacy on frontal lobe dysfunctions and anger rumination in patients with epilepsy.

This study compared the frontal lobe functioning and anger rumination between patients with epilepsy and healthy individuals. The second objective was to examine the efficacy of levetiracetam therapy ...

LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.

Many patients with epilepsy need a second antiepileptic drug (AED), due either to inefficacy or side effects of the first tried one. We evaluated the efficacy and safety of lacosamide (LCM) as first a...

Clinical Trials [4506 Associated Clinical Trials listed on BioPortfolio]

Epilepsy Phenome/Genome Project

The purpose of this study is to collect detailed information about the characteristics and genetics of a large number of individuals with epilepsy.

Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting

This study involves a form of group therapy called Cognitive Behavioral Therapy or CBT for depressed patients with Epilepsy. The CBT groups will be tailored for an epilepsy clinic populat...

EEG@HOME (Phase 3a of the Project, Comparison of EEG-recordings)

The goal of this project is the development of an EEG-cap (min. 21 electrodes) with user-friendly active dry electrodes that meets the expectations of the users regarding comfort and esthe...

Human Epilepsy Project 2: Resistant Focal Seizures Study

The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 200 people with medication-resistant focal epil...

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.

Companies [1625 Associated Companies listed on BioPortfolio]

Epilepsy Therapy Project

Epilepsy is a neurological disorder that affects approximately three million Americans and 50 million people worldwide. Epilepsy has many potential causes, but often no definitive cause is found. A...

Epilepsy Foundation Northwest

The Epilepsy Foundation Northwest (EFNW) serves northwest states including Washington and Oregon with support to Alaska and Montana, and is an affiliate of the national Epilepsy Foundation. Over 110,...

Cyberonics Incorporated

Cyberonics, Inc. (NASDAQ: CYBX) pioneered the Vagus Nerve Stimulation (VNS Therapy™) System. Founded in 1987 to design, develop and market implantable medical devices for the treatment of epilepsy a...

Kyle and Rose Epilepsy (KARE) Foundation

Join the Kyle and Rose Epilepsy (KARE) Foundation and their partner Target for the 1st Annual E-Race Epilepsy 5K Run & Walk at the Philadelphia ...

Epilepsy Foundation of Georgia

The Epilepsy Foundation, a national nonprofit with affiliated organizations throughout the United States, has lead the fight since 1968 to stop seizures, find a cure and overcome ...

More Information about "Epilepsy Therapy Project" on BioPortfolio

We have published hundreds of Epilepsy Therapy Project news stories on BioPortfolio along with dozens of Epilepsy Therapy Project Clinical Trials and PubMed Articles about Epilepsy Therapy Project for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Epilepsy Therapy Project Companies in our database. You can also find out about relevant Epilepsy Therapy Project Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record